Biogen Inc. (VIE:BIIB)
144.90
-12.05 (-7.68%)
At close: Jan 14, 2026
Biogen Market Cap
Biogen has a market cap or net worth of €21.31 billion as of January 15, 2026. Its market cap has increased by 1.62% in one year.
Market Cap
21.31B
Enterprise Value
23.57B
Revenue
8.58B
Ranking
n/a
PE Ratio
15.55
Stock Price
€144.90
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 126.71M to 21.31B, an increase of 16,720.17%. That is a compound annual growth rate of 16.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 22.48B | 2.22% |
| Dec 31, 2025 | 21.99B | 2.16% |
| Dec 31, 2024 | 21.52B | -36.55% |
| Dec 29, 2023 | 33.92B | -9.09% |
| Dec 30, 2022 | 37.31B | 20.41% |
| Dec 31, 2021 | 30.99B | 0.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erste Group Bank AG | 40.78B |
| VERBUND AG | 21.70B |
| OMV Aktiengesellschaft | 16.14B |
| Raiffeisen Bank International AG | 12.07B |
| BAWAG Group AG | 10.01B |
| Strabag SE | 9.54B |
| Vienna Insurance Group AG | 8.33B |
| Voestalpine AG | 6.85B |